» Articles » PMID: 25347711

Isolation of Epithelial, Endothelial, and Immune Cells from Lungs of Transgenic Mice with Oncogene-induced Lung Adenocarcinomas

Overview
Date 2014 Oct 28
PMID 25347711
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Genetically engineered mouse models of lung adenocarcinoma have proven invaluable for understanding mechanisms of tumorigenesis, therapy response, and drug resistance. However, mechanistic studies focused on studying these processes in tumor-bearing mouse lungs are confounded by the fact that, in most cases, relevant signaling pathways are analyzed in whole-lung preparations, which are composed of a heterogeneous mixture of cells. Given our increasing knowledge about the roles played by different subpopulations of cells in the development of lung adenocarcinoma, separating the major cellular compartments of the tumor microenvironment is recommended to allow for a precise analysis of relevant pathways in each isolated cell type. In this study, we optimized magnetic- and fluorescence-based isolation protocols to segregate lung epithelial (CD326/epithelial cell adhesion molecule-positive), endothelial (CD31-positive), and immune (CD45-positive) cells, with high purity, from the lungs of transgenic mice with mutant epidermal growth factor receptor-induced lung adenocarcinomas. This approach, which can potentially be extended to additional lung adenocarcinoma models, enables delineation of the molecular features of individual cell types that can be used to gain insight into their roles in lung adenocarcinoma initiation, progression, and response to therapy.

Citing Articles

TAZ deficiency impairs the autophagy-lysosomal pathway through NRF2 dysregulation and lysosomal dysfunction.

Kim H, Jeong H, Jeong M, Won H, Lee G, Bae S Int J Biol Sci. 2024; 20(7):2592-2606.

PMID: 38725855 PMC: 11077375. DOI: 10.7150/ijbs.88897.


New insights into the natural history of bronchopulmonary dysplasia from proteomics and multiplexed immunohistochemistry.

Dylag A, Misra R, Bandyopadhyay G, Poole C, Huyck H, Jehrio M Am J Physiol Lung Cell Mol Physiol. 2023; 325(4):L419-L433.

PMID: 37489262 PMC: 10642360. DOI: 10.1152/ajplung.00130.2023.


microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis.

Ahangari F, Price N, Malik S, Chioccioli M, Barnthaler T, Adams T JCI Insight. 2023; 8(4).

PMID: 36626225 PMC: 9977502. DOI: 10.1172/jci.insight.158100.


Locally organised and activated Fth1 neutrophils aggravate inflammation of acute lung injury in an IL-10-dependent manner.

Wang K, Wang M, Liao X, Gao S, Hua J, Wu X Nat Commun. 2022; 13(1):7703.

PMID: 36513690 PMC: 9745290. DOI: 10.1038/s41467-022-35492-y.


PEAR1 regulates expansion of activated fibroblasts and deposition of extracellular matrix in pulmonary fibrosis.

Geng Y, Li L, Yan J, Liu K, Yang A, Zhang L Nat Commun. 2022; 13(1):7114.

PMID: 36402779 PMC: 9675736. DOI: 10.1038/s41467-022-34870-w.


References
1.
Broeckaert F, Bernard A . Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy. 2000; 30(4):469-75. DOI: 10.1046/j.1365-2222.2000.00760.x. View

2.
Cho H, Lai C, Shao L, Yu J . Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma. Cancer Res. 2011; 71(23):7250-8. DOI: 10.1158/0008-5472.CAN-11-0903. View

3.
Fehrenbach H . Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res. 2001; 2(1):33-46. PMC: 59567. DOI: 10.1186/rr36. View

4.
Jackson E, Willis N, Mercer K, Bronson R, Crowley D, Montoya R . Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001; 15(24):3243-8. PMC: 312845. DOI: 10.1101/gad.943001. View

5.
Fisher G, Wellen S, Klimstra D, Lenczowski J, Tichelaar J, Lizak M . Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 2001; 15(24):3249-62. PMC: 312852. DOI: 10.1101/gad.947701. View